Who Owns XTNT?

Xtant Medical Holdings, Inc. — Institutional Ownership & 13F Holdings

$0.52

-0.00 (-0.37%)

Market Cap

$87.8M

Shares Outstanding

140,068,000

Institutional Holders

28

Total Inst. Value

$45.3M

% of Float Held

QoQ Holder Change

Institutional data as of Q1 2025

New Positions

3

Closed Positions

6

Increased

3

Decreased

7

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1ORBIMED ADVISORS LLC$34.4M73,114,592
2Nantahala Capital Management, LLC$5.4M11,394,000
3Altium Capital Management LLC$3.4M7,252,998
4VANGUARD GROUP INC$1.1M2,251,512
5RENAISSANCE TECHNOLOGIES LLC$334K711,210
6GEODE CAPITAL MANAGEMENT, LLC$258K549,265
7Crescent Grove Advisors, LLC$99K212,024
8BRIDGEWAY CAPITAL MANAGEMENT, LLC$89K189,100
9BlackRock, Inc.$57K120,326
10Private Advisor Group, LLC$54K115,000

Biggest Buyers & Sellers This Quarter

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold XTNT?

As of Q1 2025, 28 institutional investors report holding XTNT (Xtant Medical Holdings, Inc.) in their 13F filings.

Which hedge fund owns the most XTNT?

The largest institutional holder of XTNT is ORBIMED ADVISORS LLC with $34.4M in shares.

Are institutions buying or selling XTNT?

This quarter, 3 institutions opened new positions in XTNT and 6 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.